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Abstract Ageing leaves characteristic traces in the
DNA methylation make-up of the genome. However,
the importance of DNA methylation in ageing remains
unclear. The study of subtelomeric regions could give
promising insights into this issue. Previously reported
associations between susceptibility to age-related
diseases and epigenetic instability at subtelomeres sug-
gest that the DNA methylation profile of subtelomeres
undergoes remodelling during ageing. In the present
work, this hypothesis has been tested in the context of
the European large-scale project MARK-AGE. In this
cross-sectional study, we profiled the DNA methylation
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of chromosomes 5 and 21 subtelomeres, in more than
2000 age-stratified women and men recruited in eight
European countries. The study included individuals
from the general population as well as the offspring of
nonagenarians and Down syndrome subjects, who
served as putative models of delayed and accelerated
ageing, respectively. Significant linear changes of
subtelomeric DNA methylation with increasing age
were detected in the general population, indicating that
subtelomeric DNA methylation changes are typical
signs of ageing. Data also show that, compared to the
general population, the dynamics of age-related DNA
methylation changes are attenuated in the offspring
of centenarian, while they accelerate in Down syndrome
individuals. This result suggests that subtelomeric DNA
methylation changes reflect the rate of ageing progres-
sion. We next attempted to trace the age-related changes
of subtelomeric methylation back to the influence of
diverse variables associated with methylation variations
in the population, including demographics, dietary/
health habits and clinical parameters. Results indicate
that the effects of age on subtelomeric DNAmethylation
are mostly independent of all other variables evaluated.
Keywords Ageing . Subtelomere . Epigenetics . DNA
methylation . Down syndrome . Centenarian offspring
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Introduction
Subtelomeres are transition DNA regions, ranging in
size from 10 to 300 kb, which are found between
chromosome-specific sequences and the telomeric re-
peats. Subtelomeres are poor in unique DNA sequences
and genes. Instead, they are predominantly made up of a
complex “patchwork” of blocks of sequences repeated
in low copy numbers and characterised by a good intra-
and inter-chromosomal sequence preservation [1–3].
Subtelomeric domains are considered heterochromatic
regions, similar to telomeres. For instance, they contain
HP1 protein and display histone modifications, such as
H4K20me3 and H3K9me3, which are typical of hetero-
chromatin. However, in contrast to the telomeres, the
subtelomeres contain highly repetitive CpG dinucleo-
tides, which make them prone to epigenetic regulation
via DNAmethylation [4, 5]. Telomere length is strongly
affected by telomeric and subtelomeric chromatin mod-
ifications (reviewed in [4]). Subtelomeres tend to be
strongly methylated both in humans and mice, and
telomere elongation has been shown to be associated
with subtelomeric hypomethylation, either following
knockout of DNA methyltransferase enzymes [6] or in
pathological conditions like cancer [7].
DNA methylation is among the epigenetic mecha-
nisms that allow integration of intrinsic and environ-
mental cues to shape genome functions [8]. Multiple
interconnected pathways transduce these signals to the
DNA methylation machinery, which can modify the
cytosine base by the action of the DNA methyltransfer-
ase enzymes (DNMT1 or DNMT3A/B) to form 5-
methylcytosine (5mC). 5mC, in turn, can be iteratively
modified by the ten-eleven translocation (TET) family
of proteins (TET1, TET2 and TET3) to produce the
oxidation products 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC).
These 5mC oxidation products can act as intermediary
compounds in the conversion of 5mC to unmodified
cytosine, thus providing the first steps in the pathway
for active DNA demethylation [9].
Rearrangements in the epigenetic landscape of the ge-
nome are recognized as being one of the major hallmarks
of the ageing process [10], and the study of age-related
DNA methylation changes is conceivably a promising
way towards enhancing our understanding of the molecu-
lar mechanisms of ageing [11, 12]. While the bulk of the
genome encounters a global loss of DNA methylation
during ageing, a subset of CpG sites displays age-
associated DNA methylation changes that are highly re-
producible across individuals [11, 13]. This finding
allowed the development of DNA methylation-based pre-
dictors of age, termed epigenetic clocks. First-generation
epigenetic clocks were built as predictors of chronological
age. However, it has been shown that the improved preci-
sion of epigenetic clock estimates was at the expense of
their ability to detect departures from the physiological
trajectories of ageing, possibly associated with age-
related phenotypes and diseases [14, 15]. Therefore, atten-
tion has recently been devoted also to those CpG sites that
do not necessarily display strong associations with chro-
nological age but nevertheless are informative of the devi-
ation of biological age from chronological age [13, 16].
In particular, the role of subtelomeric DNA methyl-
ation in ageing and age-related diseases is attracting an
increasing level of interest [17]. Buxton et al. demon-
strated that DNA methylation of subtelomeric se-
quences is associated with telomere length [18]. The
mechanisms underlying the regulation of subtelomeric
DNAmethylation and its functional implications are yet
to be fully understood. However, some previous reports
have demonstrated the correlation between the
subtelomeric DNA methylation and the development
of neurodegenerative disorders (i.e. Alzheimer’s disease
and Parkinson’s disease) [19–22], metabolic disorders
(i.e. diabetes) [23] and some sporadic malignancies [7,
24–28]. Since these diseases are typically associated
with ageing, these observations have led to the hypoth-
esis that alterations in the status of subtelomeric meth-
ylation might be related to the ageing process.
This hypothesis is also supported by some initial
evidence of an age-related change of subtelomeric
DNA methylation in the white blood cells of healthy
Japanese individuals [29]. However, the relationship
between subtelomeric DNA methylation and ageing
has not been investigated in large human populations
so far.
Based on these premises, the present study has
tested the association of subtelomeric methylation
with ageing in the context of a large-scale European
study, as part of the MARK-AGE project. MARK-
AGE is a Europe-wide population study, supported
by the European Commission (FP7), aiming to dis-
cover new biomarkers of ageing [30, 31]. MARK-
AGE is mainly a cross-sectional study, in which age-
stratified individuals (age range 35–75 years) were
randomly recruited between 2008 and 2013 in seven
European countries. The MARK-AGE study is
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largely representative of the general population, as
the exclusion criteria included only seropositivity for
HIV, HCV and HBV (except for seropositivity by
vaccination) and the presence of actual cancer/
current use of anti-cancer drugs or glucocorticoids.
Furthermore, subjects born from a long-living parent
belonging to a family with long-living sibling(s) and
persons with progeroid syndromes were included as
models of successful and unsuccessful ageing, re-
spectively. Anthropometric, clinical and social data
have been collected in a standardised manner, and a
wide range of potential biomarkers of age was tested.
Here, we assessed the DNA methylation status of
two subtelomeric regions. We analysed their variation
with age in peripheral blood mononuclear cells (PBMC)
from more than two thousand age-stratified donors (35–
75 years), representative of the general population of
eight European countries [31].
Our results indicate that age indeed influences the
methylation level and patterns of the subtelomeres in
PBMC. This association did not significantly depend on
several nutritional, lifestyle or clinical variables, which
influence subtelomeric DNA methylation in the
population.
This study also took into consideration subtelomeric
DNA methylation in models of successful (subjects
born from a long-lived parent) and unsuccessful (sub-
jects affected by Down syndrome, DS) ageing [31].
The study of these two subgroups provided further
validation of the relationship between subtelomeric
methylation and ageing, as the age-related methylation
dynamic of the subtelomeres was consistent with their
putative divergent rate of ageing.
Methods
Study design, recruitment, data and blood cell collection
The details of the MARK-AGE project have been the
subject of previous publications, to which we refer for
the study design [30, 31], data collection (i.e. demo-
graphic, anthropometric, clinical and social data) [32],
the standard operating procedures (i.e. subject recruit-
ment, collection, shipment and distribution of biological
samples) [33] and management and processing of the
MARK-AGE database [34, 35].
PBMC isolation procedure has been previously
described [33, 36]. Briefly, the PBMC were isolated
from EDTA whole blood, obtained by phlebotomy
after overnight fasting, by discontinuous density
gradient centrifugation in Percoll and subsequently
cryopreserved to allow shipment, distribution and
storage of the samples until analysis.
DNA extraction
The PBMC samples were thawed by incubation at
37 °C, followed by dropwise addition of RPMI contain-
ing 10% FCS to a final dilution of 1:20. Cells were
collected by centrifugation and processed for DNA
extraction.
Isolation of total DNA was performed using the
QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germa-
ny) according to the manufacturer’s instructions. DNA
concentration, purity and integrity were evaluated as
previously described [37].
Quantitative DNA methylation analysis
The EpiTYPER assay (Sequenom, San Diego, USA)
[38] was used to quantitatively assess the DNA
methylation of two subtelomeric regions located in
the short arm of chromosome 5 (5p; chr5:12,038–
12,237 in the GRCh37/hg19 assembly) and in the
long arm of chromosome 21 (21q), respectively.
DNA (1 μg) was bisulphite-converted using the
EZ-96 DNA Methylation Kit (Zymo Research, Ir-
vine, USA) with the following modifications: incu-
bation in CT buffer for 21 cycles of 15 min at 55 °C
and 30 s at 95 °C, elution of bisulphite-treated DNA
in 100 μl of water. Bisulphite-specific primers were
des igned us ing the Ep iDes igner so f twa re
(https://www.epidesigner.com) and checked by
SYBR Green-based melt curve to evaluate the spec-
ificity of the amplification. The selected primers
amplified the following regions, annotated in the
GRCh37/hg19 assembly: chr5:12,038–12,237 (5p
Fw: aggaagagagTTTTTTTTATTATAGATGTT
G G G G G ; 5 p R v : c a g t a a t a c g a
c t cac t a t agggagaaggc tCCCAAACCTTCCTT
AAAAACATCT); chr21:48,081,403-48,081,721: 21
q Fw: aggaagagagGTTTTGTTGTGGAAAGGTTT
A G T T ; 2 1 q R v : c a g t a a t a c g a c t c a c t a
tagggagaaggctCCCTCAAAATCTAAATCAAA
CAAAT. PCR was performed on 10 ng of converted
DNA.
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Statistical analysis
Batch effect correction of methylation data was per-
formed via the Partek Genomic Suite 6.6 implemented
with the ANOVA tool (Partek Incorporated). We con-
sidered each EpiTYPER experimental plate (containing
about 100 samples with study groups not evenly distrib-
uted across plates) as a batch.
For continuous variables, normal distribution of data
was verified by the Kolmogorov–Smirnov and Shapiro–
Wilk normality tests (data not shown) as previously
described [36]. Identification and handling of outliers
were performed as previously described [36].
The characteristics of the study population across age
groups were analysed by the one-way-ANOVA (con-
tinuous variables) or chi-square test (categorical
variables).
Associations between variables have been analysed
by both parametric and non-parametric tests. The gen-
eralised linear model (GLM) method was used as a
parametric approach for comparisons between groups.
The GLM was also used to investigate the influence of
confounding variables (tested as categorised and contin-
uous variables). The Kruskal–Wallis (KW) method was
used as a non-parametric approach to compare between
groups. When a significant p value was found, pairwise
comparisons (adjusted for multiple comparisons by
Bonferroni’s and Dunn’s methods for the GLM and
the KW tests, respectively) were used to identify signif-
icant differences between groups. The GLM and KW
test included categorical and categorised continuous
variables as predictors. Associations between continu-
ous variables were also investigated by linear regression
using both parametric (Pearson) and non-parametric
(Spearman) correlations. Correlations were additionally
investigated by stratified bootstrap sampling (1000
bootstrap samples). Effect sizes in the GLM and KW
tests were estimated by the eta square (η2) and epsilon
square (ε2) indexes (η2 values ≅ 0.01, ≅ 0.06 and > 0.14
indicate weak, moderate and strong effect sizes, respec-
tively; ε2 values <0.04, <0.16, <0.36 and > 0.36 indicate
weak, moderate, relatively strong and strong effect
sizes, respectively).
For the generation of the Methylation Age of
SubTelomere index (MAST), we adopted a strategy based
on regression analysis for multiple biomarkers. Briefly,
methylation levels of all CpG sites were combined by
linear regression using age as dependent variable in the
randomly recruited age-stratified individuals from the gen-
eral population (RASIG). MAST was then calculated in
GO, SGO and DS as the sum of the methylation levels of
each CpG site multiplied by its corresponding coefficient
derived from RASIG (MAST=Constant +∑ linear re-
gression coefficient of methylation level of CpG×meth-
ylation level of CpG).
All statistical analyses were carried out using SPSS




The population under study consisted of 3155 individ-
uals divided into three groups (Table 1). The largest
group, representative of the “average” ageing popula-
tion, consisted of randomly recruited age-stratified indi-
viduals from the general population (RASIG) of seven
European countries covering the age range of 35–
75 years. Stratification of RASIG into four consecutive
10-year age groups guaranteed an almost homogenous
distribution of sample size, a balanced sex ratio and a
broad area of origins across the whole age range studied.
A second group represented a presumed model of
successful or “retarded” ageing. It consisted of the off-
spring of nonagenarians, allegedly predisposed to lon-
gevity because of their genetic background. This group
has been previously studied in the framework of the
GEHA (Genetics of Healthy Ageing) project [39] and
is hereafter referred to as GO (GEHA offspring). To
check for lifestyle and environmental effects, the GO
group was compared to the group of their spouses,
which was named the SGO (spouses of the GO) [31]
group. Both groups covered the age range of 55–
75 years.
Finally, subjects affected by DS, a known segmental
progeroid syndrome, were considered as a model of
premature/accelerated ageing [31].
Being composed of quite rare individuals, the GO,
SGO and DS groups show limited sample size, a not
wholly balanced sex ratio in some age groups and a
limited geographical distribution of sample origin.
The body mass index (BMI) appeared to increase
with age in RASIG and is consistently higher in SGO
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was effectively representative of a physiological ageing
process.
Characteristics of the analysed subtelomeric regions
Subtelomeric DNA methylation was quantified in
PBMC-derived genomic DNA using the EpiTYPER
assay. This assay measures the methylation percent-
age of single CpG sites or groups of adjacent sites,
termed CpG units, included in a target genomic se-
quence. Two target sequences were selected among
the subtelomeres that have low structural variation
and lack sequence gaps and large duplications [40,
41]: the first one is located on the short arm of
chromosome 5 (5p) and includes 3 detectable CpG
sites; the second one is located in the long arm of
chromosome 21 (21q) and includes 18 detectable
CpG sites, grouped in 10 CpG units. The localisation
of the target genomic sequences and the CpG sites
covered by the analysis are shown in Fig. 1.
Methylation changes of the subtelomeric CpG sites
with age in the general population
The relationship between variation in subtelomeric
methylation and physiological ageing was investigated
in the RASIG group, representative of the general pop-
ulation in the chronological age range of 35–75 years.
The association between CpG methylation level and
age was investigated both by an age stratification ap-
proach and by linear correlation analysis. By comparing
the 10-year age groups, we observed a progressive
increase in methylation with increasing age of most of
the CpG sites on both subtelomeres, as well as an
increase of the mean subtelomeric methylation calculat-
ed in each individual (Supplementary Table S1). The
significance of these associations was confirmed by
both non-parametric (Kruskal–Wallis, KW) and para-
metric (generalised linear model, GLM) tests, the latter
accounting for the effects of sex and recruitment centre
as potential confounding factors. One exception was the
21q CpG unit 1.2 which was significantly associated
with age only in the GLM. Pairwise comparison tests
indicated that the differences mainly concerned the most
extreme age groups. These data are shown graphically
in Fig. 2.
All CpG sites showed a weak positive, albeit highly
significant, linear correlation with age, both in non-
parametric (Spearman) and parametric (Pearson) tests,
which included a bootstrap stratified resampling in order
to control for the effects of sex and recruitment centre
(Supplementary Table S2 and Fig. 3).
Generation of a cumulative epigenetic age predictor
by combining the age-related DNA methylation
changes on 5p and 21 q subtelomeric regions
Based on the highly concordant linear association of all the
CpG sites with age, we chose to create a summary index
that illustrates the cumulative importance of the DNA
methylation of all sites in predicting age. Several multiple
linear regression methods were tested in the RASIG pop-
ulation using the methylation value of all the 5p and 21q
CpG sites as the predictor variables and age as the response
variable (Supplementary Table S3, methods 1–8). Method
1 (linear regression based on enter method) outperformed
all other methods in modelling the relationship between
age andDNAmethylation changes as it provided predicted
values with the highest correlation vs age in both paramet-
ric (R = 0.176, p < 0.001) and non-parametric tests (R =
Fig. 1 CpG distribution of the 5p and 21q subtelomeric regions.
Schematic representation of CpG site distribution within the
analysed regions. Green and red circles represent the analysed
and non-analysed CpG sites, respectively. The dashed boxes indi-
cate the CpG sites that were measured as single methylation units
in the EpiTYPER assay. The genomic positions refer to the 2009
(GRCh37/hg19) assembly
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0.174 p < 0.001). Further details on this regression model
are given in Supplementary Table S4. Notably, the coeffi-
cient of determination (R= 0.254) of the model was higher
than the association with age of each of the CpG sites
methylation in the binary correlation analyses (Supplemen-
tary Table S2). This indicated that the combined model
was more informative for age prediction than the methyl-
ation values of each single CpG site. The linear predictor of
the model was therefore used to combine the methylation
status of all CpG sites into a single subtelomeric DNA
methylation age index (from now on referred to as Meth-
ylation Age of SubTelomeres or MAST) for each
Fig. 2 DNA methylation level of the 5p and 21q subtelomeres in
RASIG stratified by age. a Methylation percentage of the CpG
sites in the 5p subtelomeric region. b Methylation percentage of
the CpG sites in the 21q subtelomeric region. cMean methylation
percentage calculated from all the CpG sites of the 5p and 21q
subtelomeres. Data are depicted by box-and-whisker plots. The
horizontal line indicates the median. The lower and the upper edge
of the box show the first and the third quartile, respectively. The
whiskers show the maximum and the minimum data values.
Pairwise comparisons resulting in a significant Kruskal–Wallis
test are indicated by the asterisks. *p < 0.05, **p < 0.01,
***p < 0.001
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Fig. 3 Correlation between the
DNA methylation level of the 5p
and 21q subtelomeres and age in
RASIG. a CpG methylation
percentage and average
methylation percentage of the 5p
subtelomere. b CpG methylation
percentage and average
methylation percentage of the 21q
subtelomere. Data are depicted by
scatterplots, including the line of
best fit
1291GeroScience (2021) 43:1283–1302
individual. The linear regression coefficients, calculated
from theRASIG group, were then used to computeMAST
in all the other populations (GO, SGO,DS) included in this
study.
Notably, given the relatively low coefficient of de-
termination of the model, MAST should not be regarded
as a DNA methylation-based predictor of age (in other
words, MAST is not an epigenetic clock) but as a
cumulative index measuring the combined age-related
DNA methylation changes of the 5p and 21q
subtelomeric regions.
Association of MAST with age and telomere length
in the general population
Stratification analysis was used to further evaluate the
association ofMASTwith age. As shown by a GLM test
adjusted for sex and recruitment centre, a significant
increase of MAST was detected with increasing age in
RASIG (Table 2 and Fig. 4). Non-parametric tests con-
firmed this trend (Supplementary Table S5).
In order to investigate the possible functional impor-
tance of subtelomeric DNAmethylation, we next exam-
ined the relationship between MAST, telomere length
and age. In fact, subtelomeric DNA methylation is
known to be closely related to the control of telomere
length, and telomere shortening is associated with the
ageing process. A correlation analysis showed that the
positive relationship between MAST and age was
paralleled by an inverse association between telomere
length and age (Supplementary Table S6). These find-
ings indicated that the increase in MAST with age could
be associated with telomere shortening. In fact, a signif-
icant, albeit very weak in magnitude, negative
correlation between MAST and telomere length sup-
ported such a connection (Supplementary Table S6).
The difference in the correlation coefficient of MAST
with age from that reported in Supplementary Table S4
may be due to the limited number of subjects tested for
the telomere length included in this last analysis.
Analysis of MAST in the offspring of nonagenarians
and in persons affected by Down syndrome
To evaluate the association between subtelomeric DNA
methylation and ageing progression, MAST was
analysed in the GO and DS groups as models of decel-
erated and accelerated ageing, respectively.
We tested if MAST was able to distinguish GO
from SGO. Age-matched RASIG individuals (55–
75 years) were used as an additional normal ageing
control group. As reported in Fig. 5, significant dif-
ferences between the two age subgroups (55–64 and
65–75) were found in the RASIG and in the SGO
groups, but not in the GO group. Furthermore, in the
65–75 age group, MAST was significantly lower in
GO compared to SGO and RASIG. A GLM test
adjusted for sex and recruitment centre, as well as
non-parametric comparison tests, confirmed this re-
sult (Table 3 and Supplementary Table S5).
A similar analysis was performed on DS. Due to the
limited sample size of the DS group, the analysis was
limited to the age range of 35–54 years. Age- and
recruitment centre–matched RASIG individuals were
used as a control group. Again, significant differences
in MAST between the two age subgroups (35–44 and
45–54) were found in the RASIG but not in the DS
group (Fig. 6). MAST mean values in DS were signif-
icantly higher than those of 35–44-year-old RASIG. A
GLM test adjusted for sex, as well as non-parametric
comparison tests, confirmed this result (Table 4 and
Supplementary Table S5).
Investigation of factors associated with subtelomeric
DNA methylation changes in the general population
An extensive set of data on demographics, anthropo-
metric and clinical parameters have been collected
from RASIG, GO and SGO subjects enrolled in the
MARK-AGE study [30]. A subset of these parame-
ters, possibly implicated in DNA methylation and
t e l ome r e homeos t a s i s , wa s eva l u a t ed f o r
its association with MAST changes in RASIG. These
Table 2 GLM analysis of the methylation age of subtelomeres
(MAST) by age in RASIG
Variables Type III
Wald chi-square df Sig.
Age group 134.080 3 < 0.001
Sex 2.181 1 0.140
Recruitment centre 3.773 1 0.052
Model: MAST (s), response variable; age group (o), factor vari-
able; sex (n) and recruitment centre (n) were included as covariates
(o, ordinal variable; n, nominal variable; s, scale variable). Type
III, type III sum of squares. Bold text indicates a statistically
significant p value
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included demographic and anthropometric data (Sup-
plementary Table S7), self-reported dietary and life-
s t y l e h a b i t s ( S u p p l emen t a r y T a b l e S 8 ) ,
cardiovascular/diabetes risk factors (Supplementary
Table S9) and expression of components of the
DNA methylation molecular machinery in PBMC
(Supplementary Table S10). Moreover, differential
white blood cell count data were used to monitor the
effect of changes in the PBMC sample composition
(Supplementary Table S11). The analysis was per-
formed by comparing MAST levels between RASIG
individuals stratified into consecutive subgroups ac-
cording to the variable of interest. Comparisons were
performed by both non-parametric (KW) and para-
metric (GLM) tests. The latter allowed for confound-
ing variables adjustment (i.e. sex and recruitment
centre). The magnitude of the difference in MAST
between subgroups (effect size) was estimated by
Fig. 5 Level of MAST in GO vs
SGO and RASIG stratified by
age. Data are represented by
mean ± S.D. Pairwise
comparisons resulting in a
significant GLM analysis,
followed by least significant
difference (and Bonferroni) post
hoc tests, are indicated by the
asterisks. The GLM was adjusted
for sex and recruitment centre.
*p < 0.05, **p < 0.01,
***p < 0.001
Fig. 4 Level ofMAST in RASIG
stratified by age. Data are
represented by mean ± S.D.
Pairwise comparisons resulting in
a significant GLM analysis,
followed by Bonferroni post hoc
test, are indicated by the asterisks.
The GLM was adjusted for sex
and recruitment centre. *p < 0.05,
**p < 0.01, ***p < 0.001
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calculating the η2 and the ε2 for the GLM and KW
tests, respectively.
Several associations were identified by the KW test
but were disproved by the GLM. These included the
BMI, French fries and whole bread consumption, serum
levels of glucose, total cholesterol and free fatty acids.
The connection of these factors to MAST seemed,
therefore, to be spurious and strongly influenced by
confounding factors (i.e. sex and recruitment centre).
Conversely, the association of MAST with glycated
haemoglobin A1c was proved only by the GLM, which
indicated that sex and recruitment centre were acting as
positive confounders.
Based on the congruence between the KW and GLM
tests, several factors appeared to be significantly associ-
ated with MAST.
Among demographics, the recruitment centre had an
impact, evidently due to the samples recruited in Austria
(Supplementary Table S7).
An influence of dietary/lifestyle habits on MAST
was attributable to the consumption of white bread and
alcoholic beverages (Supplementary Table S8). In both
cases, increased MAST was detectable between the
moderate- and high-consumption groups. In the case
of white bread consumption, the GLM attenuated the
significance of the association detected by the KW,
Fig. 6 Level of MAST in DS vs
RASIG stratified by age. Data are
represented by mean ± S.D.
Pairwise comparisons resulting in
a significant GLM analysis,
followed by least significant
difference (and Bonferroni) post
hoc tests, are indicated by the
asterisks. The GLM was adjusted
for sex and recruitment centre.
*p < 0.05, **p < 0.01,
***p < 0.001
Table 3 GLM analysis of MAST in GO vs SGO and RASIG in the population aged >54 years controlling for sex and recruitment centre
Variables Type III
Wald chi-square df Sig.
Subject group (GO, SGO, RASIG) 8.943 2 0.011
Age group 15.199 1 < 0.001
Sex 0.658 1 0.417
Recruitment centre 0.524 1 0.469
Model: MAST (s), response variable; subject group (n), factor variable; age group (o), sex (n) and recruitment centre (n) were included as
covariates (o, ordinal variable; n, nominal variable; s, scale variable). Type III, type III sum of squares. Bold text indicate a statistically
significant p value
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indicating a partial confounding effect by sex and re-
cruitment centre.
Regarding cardiovascular risk biomarkers (Supple-
mentary Table S9), serum triglycerides, low-density
lipoprotein cholesterol (LDL-C) and fibrinogen showed
a significant positive association with MAST, although
the effect of the confounding variables attenuated the
association of LDL-C in the GLM analysis.
In the analysis of the association of MAST with the
expression of enzymes involved in the methylation/
demethylation processes (Supplementary Table S10), a
significant association was found for DNMT1,
DNMT3A and TET3. MAST increased in the upper
quantiles of DNMT1 and DNMT3A expression, while
it decreased in the case of TET3.
Among haematological parameters (Supplementary
Table S11), MAST was associated with peripheral
blood lymphocyte and neutrophil count and with the
lymphocyte to monocyte count ratio. Differences main-
ly concerned the 1st vs the 4th quartiles. This associa-
tion was positive for the lymphocyte count and the
lymphocyte/monocyte count ratio, while it was negative
for neutrophils count.
Most of the reported MAST associations showed
weak effect sizes, except for TET3 and DNMT3A ex-
pression that showed moderate and relatively strong
effect sizes, respectively.
The contribution of selected variables on age-related
changes in MAST in the RASIG and GO/SGO
population
The variables found to be associated with MAST were
next studied as potential causative factors in the
association of MAST with age in RASIG and in its
difference between the GO, SGO and RASIG groups.
Due to sample size limitations, data on DNMT3A,
TET and TDG expression were excluded from the
analyses.
The effect on the relationship between MAST and
age in RASIG was examined by GLM analysis. The
model tested MAST differences between the 10-year
age strata, adjusted for all the factors that significantly
affected MAST level as previously shown by both KW
and GLM analyses (see Supplementary Tables S7–
S11).
As shown in Table 5, none of the variables confound-
ed the association of MAST with age groups, which, in
fact, retained a highly significant p value (p < 0.001, see
Table 2 for comparison) despite the inclusion of all the
covariates. However, the DNMT1 transcript level and
alcohol consumption seemed to have a certain weight in
the model (Table 5).
Similar results were obtained by running several
additional GLM models with the progressive inclusion
of all theMAST-associated variables, categorised on the
Table 5 Contribution of selected variables and covariates on age-
related changes of MAST in RASIG
Source Type III
Wald chi-square df Sig.
Age group 72.680 3 <0.001
Recruitment centre 2.635 1 0.105
Sex 0.935 1 0.334
White bread consumption 0.032 1 0.858
Alcohol consumption 4.011 1 0.045
Triglycerides 1.825 1 0.177
LDL cholesterol 1.850 1 0.174
Lymphocytes 0.201 1 0.654
Lymphocyte to monocyte ratio 1.779 1 0.182
Neutrophils 0.552 1 0.45
Fibrinogen 3.604 1 0.058
Relative DNMT1 expression 4.578 1 0.032
Model: MAST (s), response variable; age group (o), factor vari-
able; sex (n), recruitment centre (n), white bread consumption (s),
alcohol consumption (s), triglycerides (s), LDL cholesterol (s),
lymphocytes (s), ratio of lymphocyte to monocyte (s), neutrophils
(s), fibrinogen (s) and DNMT1 expression (s) were included as
covariates (o, ordinal variable; n, nominal variable; s, scale vari-
able). Type III, type III sum of squares. Bold text indicates a
statistically significant p value
Table 4 GLM analysis of MAST in DS vs RASIG in the age
range of 35–55 years
Variables Type III
Wald chi-square df Sig.
Subject group (DS, RASIG) 8.334 1 0.004
Age group 9.421 1 0.002
Sex 4.416 1 0.036
Model: MAST (s), response variable; subject group (n), factor
variable; age group (o) and sex (n) were included as covariates
(o, ordinal variable; n, nominal variable; s, scale variable). Type
III, type III sum of squares. Bold text indicated a statistically
significant p value
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basis of having any significant association with MAST
(i.e. also including variables showing significant inter-
action after the KW or GLM only) (Supplementary
Table S12).
The crude models (models 1–4) included “stan-
dard” adjustment variables (recruitment centre, sex
and lymphocyte to monocyte ratio). We next added
to these crude models all the variables—one by
one—associated with MAST either by both the
GLM and KW tests (models 5–12) or by only one
of the tests (models 14–19). The order in which the
variables were added followed the criterion of
obtaining the minimum reduction in the number of
cases included in the model. Models 13, 20 and 21
accounted for the effect of all the potential con-
founding variables simultaneously. Models 20 and
21 differ for the inclusion of DNMT1 expression,
which was the variable causing the greatest reduc-
tion in sample size.
No significant confounding effect on MAST varia-
tion across age groups was observed by any of the
covariates. In fact, the association of MAST with age
groups remained highly significant in all the tested
models. Nevertheless, based on their significant
p values, DNMT1, glucose, glycated haemoglobin and
alcohol were found to be explanatory variables in the
cumulative model (model 21) that contained all the
other factors.
Conversely, the significance showed by other co-
variates (e.g. recruitment centre, sex, BMI, fibrino-
gen and LDL-C) in some of the models was depen-
dent on the effect of other adjusting variables. In fact,
their p value became non-significant in the cumula-
tive models.
The same analyses were performed to test the varia-
tion of MAST between GO, SGO and RASIG.
The confounding effect of the factors associated with
MAST in both the KW and GLM tests was negligible,
both in the cumulative (Table 6) and in the stepwise
analysis (Supplementary Table S13, models 1–14). The
expression of DNMT1 and the lymphocyte to monocyte
ratio were the covariates partially affecting MAST dif-
ferences across subject groups (Table 6 and
Supplementary Table S13, model 14). However, the
significance of the association between MAST and sub-
ject groups was partially affected by the combination of
all factors rather than by a single one (see the subject
group p value in models 1–13 with respect to model 14
in the Supplementary Table S13).
Similar conclusions could be drawn from the analysis
of factors associated with MAST by the KW or the
GLM tests. Each additional factor was, by itself, inef-
fective in explaining MAST association with subject
groups (Supplementary Table S13, models 15–20), but
the inclusion of all factors made this relationship not
significant (p value = 0.065 in model 22).
The loss of significance of subject groups seemed to
be driven by two factors: (i) a drop in the sample size
whenDNMT1 expression was entered in the model and/
or (ii) to a synergy between DNMT1 expression and
other variables, such as the lymphocyte/monocyte ratio
(see model 21 vs model 22).
After the removal of DNMT1, the association of
MAST with the subject groups regained a borderline
significance (p value = 0.045 in model 21). Com-
pared to previous models, the decrease in signifi-
cance for the subject groups in this model could be
due to the confounding effect of BMI, glycated
haemoglobin, French fries and glucose, as well as
to a smaller sample size.
Table 6 Contribution of selected variables and covariates on
group-related (GO, SGO and RASIG) changes of MAST in indi-
viduals aged >54 years
Source Type III
Wald chi-square df Sig.
Subject group (GO, SGO, RASIG) 8.485 2 0.014
Age 12.077 1 0.001
Recruitment centre 0.153 1 0.695
Sex 0.518 1 0.472
Alcohol consumption 1.345 1 0.246
White bread consumption 0.013 1 0.909
Triglycerides 0.019 1 0.890
LDL cholesterol 0.962 1 0.327
Fibrinogen 2.584 1 0.108
Lymphocytes 0.344 1 0.557
Lymphocyte to monocyte ratio 4.671 1 0.031
Neutrophils 0.358 1 0.550
Relative DNMT1 expression 4.369 1 0.037
Model: MAST (s), response variable; subject group (o), factor
variable; age (s), sex (n), recruitment centre (n), white bread
consumption (s), alcohol consumption (s), triglycerides (s), LDL
cholesterol (s), lymphocytes (s), ratio of lymphocyte to monocyte
(s), neutrophils (s), fibrinogen (s) and DNMT1 expression (s) were
included as covariates (o, ordinal variable; n, nominal variable; s,
scale variable). Type III, type III sum of squares
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Discussion
Previous studies indicate the possibility that epigenetic
changes occur at subtelomeric DNA regions in both
physiological and abnormal ageing [19–23, 29, 42].
Here, this hypothesis has been tested in the context of
a large-scale population-based study, which also pro-
vides a reference framework for factors that are associ-
ated with subtelomeric DNA methylation variation in
the general population including demographics, clinical
laboratory parameters, dietary and health habits. Fur-
thermore, this study adopts the innovative approach of
validating the identified putative subtelomeric methyla-
tion signature of ageing in highly informative groups
represented by offspring of nonagenarians and subjects
affected by Down syndrome, representing models of
healthy ageing [43] and premature/accelerated ageing
[44], respectively.
The method adopted for methylation analysis
(EpiTYPER [38]) enabled us to get a quantitative mea-
sure of subtelomeric DNA methylation in blood mono-
nucleated cells, largely at single-nucleotide resolution.
Data obtained provided an unprecedented opportunity
to systematically analyse the subtelomeric methylation
profile and its variation with age in the general
population.
The CpGs showed an intermediate level of methyla-
tion possibly reflecting an epigenetic heterogeneity
across principal immune cells that form the PBMC
population. However, this heterogeneity may also con-
form to variation within cell types, since varying de-
grees of subtelomeric methylation were reported in oth-
er studies even in cultured primary cells [45].
Nevertheless, each CpG site showed a limited range
of methylation variation, thus forming a methylation
pattern that appeared to be specific to the subtelomeric
region. The methylation profile of subtelomeres seems
therefore to be controlled by specific mechanisms and
might reflect certain functions as it has recently been
proposed for other regions showing intermediate meth-
ylation states in the human genome [46]. CpG methyl-
ation levels increased with age at almost all the assessed
CpG sites. Moreover, the rate of increase of methylation
with age seems to be similar across the different CpG
sites. Consequently, the average methylation of the en-
tire subtelomeric region increases without significant
changes in its variability. This suggests that age-related
hypermethylation of subtelomeres does not evolve ran-
domly, unlike many other age-associated differentially
methylated regions, where ageing is associated with an
entropic decay of the epigenetic profile [47].
Overall, these findings contrast with previous results
showing an age-related hypomethylation of global
subtelomeric regions in blood from healthy individuals
[29] and patients affected by age-related diseases such
as Parkinson’s disease [21]. There are several possible
explanations for this discrepancy. Firstly, compared to
Maeda et al. [29], our cohort of cases was significantly
more extensive and representative of a different and
more heterogeneous geographical area. Secondly, we
adopted an analytical method that has an advantage over
the methylation-sensitive Southern blot assay used by
Maeda et al., both in terms of quantitative accuracy and
the number of CpG sites that can be assessed individu-
ally. Finally, we focused on two specific subtelomeric
regions, while Maeda et al. evaluated the global meth-
ylation status of subtelomeres. This last point is of
particular relevance since the methylation status of a
subtelomeric region and its variation with age may
depend on its specific chromosomal context, including
the length of the adjacent telomere end. It is, therefore,
possible that the increase in methylation with age re-
ported here for 5p and 21q subtelomeric regions reflects
their specific chromosomal context and represents the
trend of a specific subset of the telomeres.
DNA methylation appears to change at a constant rate
across age groups, indicating a linear relationship with
chronological age. Regression analyses actually show a
significant direct correlation between age and methylation
level for all CpG sites. However, the proportion of meth-
ylation variation explained by age was small for every
single site. By contrast, a subtelomeric DNA methylation
index (MAST) based on the aggregate methylation status
of all CpG sites provided a better fit with age and
outperformed every single site in discriminating between
age groups. Biologically, this suggests that the amount that
each CpGmethylation contributes to age is additive and/or
that additional information may come from the effects of
age on the DNA methylation pattern of the whole
subtelomeric region.
This point should also be taken into account when
interpreting the negative correlation between MAST
and the average length of the bulk telomere population
shown in Supplementary Table S6. These results are
consistent with previous observations linking a loss of
subtelomeric methylation to telomere elongation [6, 7]
and suggest that subtelomeric DNA hypermethylation is
related to telomere shortening in ageing. However, this
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association might not involve all of the subtelomeres. In
fact, it has been suggested that the correlation between
subtelomeric methylation and telomere length is vari-
able, in terms of both strength and direction, across
different chromosomes and/or different regions of the
same subtelomere [27]. This insight could also offer a
plausible explanation for the observation that the
amount of the telomere length variation explained by
MAST is relatively small.
Remarkably, MAST was more correlated with age
than with telomere length. This finding suggests that
part of the DNA methylation ‘signature’ of age in
subtelomeres is not related to telomere length control.
DNA methylation could also affect the expression of
genes related to ageing via the telomere position effect
(TPE) [48] and/or by controlling transcription of the
non-coding telomeric RNAs (TERRA), recently de-
scribed as trans-acting epigenetic modulators of multi-
ple genes throughout the genome [49].
The trend ofMAST in the GO and DSwith respect to
RASIG further supports a link of subtelomeric methyl-
ation and the ageing process. Higher MAST in DS is
compatible with the accelerated ageing phenotype of
this syndrome and mirrors previous data indicating that
telomere length maintenance processes are impaired in
DS [50, 51]. In contrast, lower MAST in GO is in
agreement with the notion that offspring of long-lived
parents show slower ageing [43, 52] and improved
telomere length maintenance [53–55] compared to nor-
mal ageing subjects.
To investigate possible sources of variation ofMAST
in the general population, we next adopted a multidi-
mensional approach that integrates demographic,
dietary/lifestyle and clinical data.
Concerning demographic variables, a variation of
MAST was found by country. This association, which
was predominantly driven by samples from Austria,
seems to be spurious and generated by the effect of third
variables (e.g. age, BMI, alcohol and white bread con-
sumption; see Table S12).
Although nutritional and lifestyle factors are believed
to be significant modifiers of epigenetic patterns, MAST
was independent of most of them except for the con-
sumption of white bread and alcoholic beverages.
The positive relationship between white bread con-
sumption and MAST is difficult to interpret since there
are no previous reports regarding this association. Howev-
er, there is initial evidence that dietary patterns, typified by
higher intakes of refined grains, are associated with DNA
methylation alterations [56] and telomere shortening [57].
The possible underlying mechanisms include epigenetic
alterations induced by higher oxidative stress or an imbal-
anced supply of nutrients that act as methyl donors or
cofactors in the one-carbon metabolism pathway.
The association of MAST with alcohol consumption
is in line with previous observations [58, 59] and further
supports the idea that chronic alcohol consumption in-
fluences genomic DNA methylation pattern. Within
subtelomeric DNA, alcohol-induced hypermethylation
is likely to have an impact on the telomere length
homeostasis. In fact, subtelomeric DNA hypermethyla-
tion has been associated with telomere shortening in
ethanol-treated cells [60].
A multitude of studies indicate a relationship between
telomere shortening in blood cells and dyslipidaemia- and
hyperglycaemia-related diseases (reviewed in [61]). Fur-
thermore, recent follow-up studies have advocated that
telomere shortening is a long-term marker of cellular
ageing, illustrating a chronic deterioration of a person’s
metabolic health [62]. In this context, the positive asso-
ciation of MAST with total blood triglycerides and LDL
cholesterol is likely to be a reflection of an underlying
mechanism translating the increased cell damage and
turnover that are secondary to elevated blood lipid levels,
to shortened telomere length [62–64].
Similarly, the positive association of MAST with fi-
brinogen levels is in agreement with previous studies that
report shorter telomeres in the blood cells of individuals
with higher levels of fibrinogen, an association that prob-
ably reflects cardiovascular ageing [65, 66].
The positive association of MAST with DNMT1 and
DNMT3A and its negative association with TET3 tran-
script levels suggest that the age-associated methylation
increase of the two subtelomeric regions reflects in part
expression changes of components of the DNA
methylation/demethylation machinery [36, 67]. This pos-
sibility is in line with previous data showing that the
modulation of the DNMT and TET expression has an
impact on subtelomeric methylation status [6, 68–70].
Finally, the association of MAST with specific
white blood cell counts may reflect pieces of evi-
dence that white blood cell types have different
rates of telomere length changes with age, which
would imply differential age-related subtelomeric
methylation changes in individual cell types. Spe-
cifically, the positive association of MAST with
lymphocyte counts agrees with previous findings
showing that this leucocyte subpopulat ion
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(especially the B-cells) exhibits higher rates of telo-
mere loss with ageing compared to other compo-
nents of the PBMC [71]. It cannot be ruled out,
however, that associations between MAST and
white blood cell counts are also influenced by the
effect of ageing on lymphocyte subpopulation num-
bers. The age-related decrease of lymphocyte
counts [71, 72] may be an additional mediating
factor in the MAST–lymphocyte count association.
The inverse association of MAST with neutrophils,
which are not part of the PBMC fraction where
MAST was measured, may reflect their decrease
in numbers with ageing [72].
After the identification of factors associated with
MAST variations in the general population, we then
sought to determine their impact on the differences in
MAST between age groups. The results showed that,
although all the critical variables were taken into
account in the analysis, the differences of MAST
between the age groups were still significant (Sup-
plementary Table S12). This would indicate that age
predicts subtelomeric DNA methylation changes in
PBMC as an almost independent variable with re-
spect to all other variables and factors evaluated here.
This result may be reminiscent of recent data show-
ing that age-related changes of specific CpGs in
blood, which are part of Horvath’s epigenetic ageing
clock (Horvath’s pan tissue 353 CpG site clock [73]),
primarily reflect cell-intrinsic properties [74, 75]. In
contrast, the influence of “extrinsic” factors is weak,
but it is nevertheless driven by multiple environmen-
tal and lifestyle factors [76]. Nevertheless, none of
Horvath’s epigenetic clock CpGs is located in or near
the subtelomeric regions here analysed. This points
to the existence of different pathways/mechanisms
underlying the clock and the epigenetic ageing of
the subtelomeres, as suggested by the observation
that the length of telomeres and the Horvath’s epige-
netic clock are independently associated with chro-
nological age and do not correlate with each other
[77].
This analysis also confirmed alcohol consump-
tion, the expression of DNMT1, blood levels of
glycated haemoglobin and glucose as important
explanatory factors. All other factors were not
associated with MAST in the GLM or olny indi-
rectly linked to it. For example, recruitment centre
and sex seem to have an effect on MAST through
other exogenous variables, including dietary/
lifestyle factors (i.e. alcohol and white bread con-
sumption), markers of carbohydrates (i.e. serum
glucose level) and lipid metabolism (i.e. blood
levels of LDL cholesterol, triglycerides and free
fatty acids).
On the other hand, the differences in MAST between
GO, SGO and RASIG seem to depend on multiple
factors, ranging from dietary habits (i.e. French fries
consumption) and metabolic fitness markers (i.e. BMI
and blood levels of glycated haemoglobin and glucose)
to molecular markers (i.e. DNMT1 expression).
These data suggest that if a more efficient con-
trol of the epigenetic status of the subtelomeres
represents a further element of the advantages that
predispose the GO to healthy ageing, this could be
related to a peculiar physiology that confers to the
offspring of long-lived subjects favourable body
anthropometrical characteristics [78] and better
glucose handling [79, 80].
Collectively, results from this study confirm in
large-scale population settings that ageing has an
impact on the methylation profile of subtelomeric
DNA. These data, together with the identification
of factors that are associated with subtelomeric
DNA methylation variation, could be helpful for
future research aimed at understanding the mecha-
nisms underlying the ageing process.
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plementary material available at https://doi.org/10.1007/s11357-
021-00347-9.
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